Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies

INTRODUCTION: The emergence of drug resistance and cross-resistance to existing drugs has warranted the development of new antivirals for Herpes simplex viruses (HSV). Hence, we have designed this study to evaluate the anti-viral activity of 1-[(2-methyl benzimidazole-1-yl) methyl]-2-oxo-indolin-3-y...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Virol J
Auteurs principaux: Kumar, Abhishek, De, Saikat, Moharana, Alok Kumar, Nayak, Tapas Kumar, Saswat, Tanuja, Datey, Ankita, Mamidi, Prabhudutta, Mishra, Priyadarsee, Subudhi, Bharat Bhusan, Chattopadhyay, Soma
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157732/
https://ncbi.nlm.nih.gov/pubmed/34039377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-021-01581-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires